The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field

By Whatling Carl   McPheat William   Herslöf Margareta  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1879-1893

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of 5-lipoxygenase: a therapeutic potential yet to be fully realized?

By Young R.N.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 9, 1999-09 ,pp. : 671-685

Elsevier

Access to resources Recommend Favorite

Pharmacological Inhibitors of Cysteinyl Leukotrienes Biosynthesis: Therapeutic Implications

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 3, Iss. 2, 2004-06 ,pp. : 157-165

Bentham Science Publishers

Access to resources Recommend Favorite

DNA hypomethylating agents 5-aza-2'-deoxycytidine and valproate increase neuronal 5-lipoxygenase mRNA

By Manev H.   Uz T.  

European Journal of Pharmacology, Vol. 445, Iss. 1, 2002-06 ,pp. : 149-150

Elsevier

Access to resources Recommend Favorite

5-Lipoxygenase: Regulation and Pharmacology

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 2, 2004-04 ,pp. : 201-223

Bentham Science Publishers

Access to resources Recommend Favorite